Defibrotide improved the outcome of monocrotaline induced rat hepatic sinusoidal obstruction syndrome.

Zhenli LiuShan LiangXinhuan WeiXiaofei DuJing Zhang

Published in: BMC gastroenterology (2022)

Defibrotide could improve the outcome of monocrotaline-induced rat HSOS indicating that defibrotide might be a better choice than LMWH in clinical practice.

Keyphrases

pulmonary arterial hypertension
pulmonary hypertension
high glucose
diabetic rats
clinical practice
oxidative stress
drug induced